28May 2022
Outcomes of carotid sparing intensity‐modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD‐01‐007

Outcomes of carotid sparing intensity‐modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD‐01‐007

To assess and report clinical outcomes after carotid sparing intensity‐modulated radiotherapy for early-stage laryngeal cancer. After a median follow‐up of 31 months, the actuarial 1‐ and 3‐year local and locoregional control rates were 99.4% and 94.7%, 98.4% and 93%, respectively. Oncologic outcomes of patients treated with carotid sparing IMRT were excellent; comparable with historical series, with acceptable side effects.

  • #ent

Like

Save

Share